Non Invasive Prenatal Testing (NIPT) Market Research Report 2017 to 2024 presents an in-depth assessment of the Non Invasive Prenatal Testing (NIPT) including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Non Invasive Prenatal Testing (NIPT) investments from 2017 till 2024.
China Potential Non Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.
The research study focuses on Non Invasive Prenatal Testing (NIPT) major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. In this report, the Non Invasive Prenatal Testing (NIPT) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2024, growing at a CAGR of XX% between 2016 and 2024.
Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.
The research report titled “Non–Invasive Prenatal Testing (NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.
The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.
The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.
Avail Complete research data at: https://www.marketinsightsreports.com/report/purchase/0912913?mode=su
The report provides a basic overview of the Non Invasive Prenatal Testing (NIPT) industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Long–term Growth Projection and Development:
- It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
- More than 3,00,000 NIFTY tests done in 2016
- Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
- Two–Child policy is likely to boost China NIPT market
Key Companies Covered in the Report are as follows:
- Berry Genomics
- BGI Diagnosis Co., Ltd
Key Topics Covered in the Report
- 2013 – 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
- 2013 – 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
- NIPT Test Implementation in Low & Middle–Income Countries
- Key Companies Analysis
- Key Drivers and Inhibitors of the China NIPT Test Market
Then, the report focuses on major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Non Invasive Prenatal Testing (NIPT) industry development trends and marketing channels are analyzed.
Table of Contents:
- Executive Summary
- Market Size & Analysis: China Potential NIPT Test (Volume and Value)
2.1 Potential NIPT Test Volume (2013-2024)
2.2 Potential NIPT Test Market (2013 – 2024)
- Market Size & Analysis: China Actual NIPT Test (Volume and Value)
3.1 Actual NIPT Test Volume (2013 – 2024)
3.2 Actual NIPT Test Market (2013 -2024)
- Key Drivers and Inhibitors of the China NIPT Market
4.1 Market Drivers
4.2 Market Inhibitors
- Nonanvasive Prenatal Testing (NIPT) Implementation a Low & MiddleIncome Countries
- China NIPT Key Players: Company Profiles
6.1 BGI Diagnosis Co., Ltd
6.1.1 Company Introduction
6.1.2 Product Portfolio
6.1.3 NIPT Test Analysis (Volume and Value)
6.1.4 Latest Development/Updates
6.2 Berry Genomics
6.2.2 Product Portfolio
6.2.3 NIPT Test Analysis (Volume and Value)
6.2.4 Latest Development/Updates
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.